Though in our study the presence of KIT mutation did not negatively affect the attainment of CMR with DAC and TTNT, CBF‐AML patients with KIT mutations are conventionally considered to be high risk and often transplanted in first remission.38, 39. The gene discussed is KIT; the disease is acute myeloid leukemia.